These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18689159

  • 1. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
    Lerman J, Siseles N.
    Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159
    [Abstract] [Full Text] [Related]

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 3. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T, Mannella P, Genazzani AR.
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [Abstract] [Full Text] [Related]

  • 4. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K, Wycisk A.
    Wiad Lek; 2006 Feb; 59(5-6):377-82. PubMed ID: 17017486
    [Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 6. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Dec; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 7. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G, Westphalen S.
    MMW Fortschr Med; 2002 Feb 28; 144(9):30-3. PubMed ID: 11921648
    [Abstract] [Full Text] [Related]

  • 8. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S, Liebson PR, Klein LW.
    Cardiol Rev; 2004 Feb 28; 12(6):287-98. PubMed ID: 15476565
    [Abstract] [Full Text] [Related]

  • 9. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL.
    Curr Womens Health Rep; 2002 Apr 28; 2(2):89-94. PubMed ID: 12116607
    [Abstract] [Full Text] [Related]

  • 10. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M.
    J Cardiovasc Med (Hagerstown); 2009 Apr 28; 10(4):303-9. PubMed ID: 19430340
    [Abstract] [Full Text] [Related]

  • 11. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.
    Climacteric; 2005 Mar 28; 8(1):3-12. PubMed ID: 15804727
    [Abstract] [Full Text] [Related]

  • 12. [Historical perspective of hormone replacement therapy].
    Chanson P.
    Rev Prat; 2005 Feb 28; 55(4):369-75. PubMed ID: 15828614
    [Abstract] [Full Text] [Related]

  • 13. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL.
    J Reprod Med; 2000 Mar 28; 45(3 Suppl):259-73. PubMed ID: 10756507
    [Abstract] [Full Text] [Related]

  • 14. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan 28; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacology of estrogens and progestogens and cardiovascular risk].
    Boissel JP, Cornu C.
    Therapie; 1999 Jan 28; 54(3):387-92. PubMed ID: 10500456
    [Abstract] [Full Text] [Related]

  • 16. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Jan 28; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 17. Pitfalls of the WHIs: Women's Health Initiative.
    Mastorakos G, Sakkas EG, Xydakis AM, Creatsas G.
    Ann N Y Acad Sci; 2006 Dec 28; 1092():331-40. PubMed ID: 17308158
    [Abstract] [Full Text] [Related]

  • 18. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T, Jaillon P.
    Arch Mal Coeur Vaiss; 2001 Feb 28; 94(2):132-8. PubMed ID: 11265551
    [Abstract] [Full Text] [Related]

  • 19. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul 28; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular health and the menopause: the gynecologist as the patients' interface.
    Arias RD.
    Climacteric; 2006 Sep 28; 9 Suppl 1():6-12. PubMed ID: 16899438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.